Giessler Goetz A, Zobitz Mark, Friedrich Patricia F, Bishop Allen T
Microvascular Research Laboratory, Department of Orthopedic Surgery, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
J Orthop Res. 2009 Jun;27(6):763-70. doi: 10.1002/jor.20764.
The purpose of this study was to demonstrate that living bone allotransplants can incorporate, remodel, and maintain mechanical properties without long-term immunosuppression in a fashion comparable to living autotransplants. For this, viability is maintained by repair of nutrient vessels and neovascularization from implanted host-derived vasculature. Microsurgically revascularized femoral diaphysis allotransplants were transferred from young male New-Zealand-White (NZW) into 4 groups of male Dutch-Belted (DB) rabbits. Short-term immunosuppression by tacrolimus (IS, groups 4 and 5) and host-derived neovascularization (NV) from implanted fascial flaps was used to maintain viability (groups 3 and 5) as independent variables. Group 2 received neither IS nor NV. Vascularized pedicled autotransplants were orthotopically transplanted in group 1. After 16 weeks, transplants were evaluated using radiologic, histologic, biomechanical, and histomorphometric parameters. Vascularized bone allotransplants treated with both short-term IS and host-derived NV (group 5) healed in a fashion similar to pedicled autotransplants (group 1). Their radiographic scores were higher than other groups. Groups with patent fascial flaps (3 and 5) showed significantly greater neoangiogenesis than ligated controls (2 and 4). Tacrolimus administration did not affect neoangiogenesis. Elastic modulus and ultimate stress were significantly greater in autogenous bone than in allotransplanted femora. Biomechanical properties were not significantly different among allotransplants. Bone turnover was decreased with IS, but increased with NV by the implanted fascial flaps. Living allogeneic femoral allotransplants treated with short-term IS and host-derived neoangiogenesis can lead to stable transplant incorporation in this rabbit model. The combination of both factors optimizes bone healing. Transplant mineralization is improved with neoangiogenesis but diminished with IS.
本研究的目的是证明同种异体活骨移植能够以与自体活骨移植相似的方式实现骨整合、重塑并维持力学性能,且无需长期免疫抑制。为此,通过修复营养血管以及植入宿主来源的脉管系统实现新生血管化来维持移植物的活力。采用显微外科技术进行血管再通的股骨干同种异体移植物,从年轻雄性新西兰白兔(NZW)移植到4组雄性荷兰带兔(DB)体内。以他克莫司进行短期免疫抑制(IS,第4组和第5组)以及植入筋膜瓣诱导宿主来源的新生血管化(NV,第3组和第5组)作为独立变量来维持移植物活力。第2组既未接受免疫抑制也未进行新生血管化处理。第1组原位移植带血管蒂的自体移植物。16周后,采用放射学、组织学、生物力学和组织形态计量学参数对移植物进行评估。同时接受短期免疫抑制和宿主来源新生血管化处理的带血管化同种异体骨移植物(第5组),其愈合方式与带血管蒂自体移植物(第1组)相似。其放射学评分高于其他组。具有开放筋膜瓣的组(第3组和第5组)的新生血管形成明显多于结扎对照的组(第2组和第4组)。给予他克莫司不影响新生血管形成。自体骨的弹性模量和极限应力显著高于同种异体移植的股骨。同种异体移植物之间的生物力学性能无显著差异。免疫抑制使骨转换降低,但植入筋膜瓣诱导的新生血管化使其增加。在该兔模型中,接受短期免疫抑制和宿主来源新生血管化处理的同种异体活股骨移植可实现稳定的移植骨整合。这两种因素的结合可优化骨愈合。新生血管化可改善移植骨矿化,但免疫抑制会使其减弱。